Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediates in Mainland China, Singapore, Taiwan, and internationally. The company operates through Pharmaceutical Business and Fitness Business segments. It provides prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health activities. The company also provides corporate advisory services; and researches and develops medical products. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022. Kontafarma China Holdings Limited was incorporated in 2011 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of Waranty Assets Management (Hk) Limited.
Часто задаваемые вопросы
В каком секторе работает Tongfang Kontafarma Holdings Ltd (1312)?
Tongfang Kontafarma Holdings Ltd относится к сектору Материалы.
Какова текущая цена акций Tongfang Kontafarma Holdings Ltd (1312)?
По последним данным, цена акций Tongfang Kontafarma Holdings Ltd составляет 0,03 HK$, предыдущее закрытие — 0,03 HK$. За последнюю торговую сессию акции Tongfang Kontafarma Holdings Ltd выросли на 0,00 HK$, что соответствует росту на 10%.
Выплачивает ли Tongfang Kontafarma Holdings Ltd (1312) дивиденды?
Нет, Tongfang Kontafarma Holdings Ltd не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Tongfang Kontafarma Holdings Ltd (1312)?
У компании Tongfang Kontafarma Holdings Ltd бета 0.003, что указывает на более низкую волатильность по сравнению с рынком в целом.
